Clinical Trials

Toll-Free: 866.320.4573

Call Us Toll Free:

866.223.2273 x1234

Diagnostic Study of Tumor Characteristics in Patients With Ewing`s Sarcoma

Study:

A Groupwide Biology and Banking Study for Ewing Sarcoma

Rationale:

Genetic testing may help predict how cancer will respond to treatment and allow doctors to plan more effective therapy.

Purpose:

Diagnostic trial to study genetic differences in patients who have Ewing`s sarcoma.

Study Status: Completed

Recruiting:
n/a

Condition Intervention Phase
Sarcoma Other: laboratory biomarker analysis N/A

Verified by Children`s Oncology Group April, 2013

Sponsored by: Children`s Oncology Group
Information provided by: Children`s Oncology Group
ClinicalTrials.gov identifier: NCT00048984

Study Type: Interventional

Study Design: Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science

Cleveland Clinic Taussig Cancer Center
Cleveland, Ohio 44195
United States

Daniel C. West, MD., Study Chair

This information is abridged to display results relevant only to Cleveland Clinic. To see complete record visit ClinicalTrials.gov
  Information obtained from ClinicalTrials.gov on
Link to the current ClinicalTrials.gov record.

Cleveland Clinic Mobile Site